• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes

byAlex ChanandRavi Shah, MD MBA
March 11, 2020
in Cardiology, Chronic Disease, Endocrinology, Gastroenterology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Smoking cessation without weight gain in patients with type 2 diabetes was associated with a lower risk of cardiovascular disease and all-cause and cause-specific mortality.

2. Weight gain after smoking cessation lessened the reduction in risk of experiencing cardiovascular events, emphasizing the importance of bodyweight control after cessation.

Evidence Rating: 2 (Good)

Lifestyle modifications, including smoking cessation, play an important role in the prevention and management of type 2 diabetes, and related macrovascular complications. Smoking cessation, however, is often accompanied by weight gain, raising concerns surrounding poorer diabetes control. In this prospective, population-based cohort study, data from the Nurses’ Health Study and Health Professionals Follow-up Study were used to investigate the association between cardiovascular disease and all-cause mortality with weight gain and smoking cessation in 10,809 patients with type 2 diabetes. Researchers found that recent quitters (2-6 consecutive years since smoking cessation) that did not have associated weight gain within this time period had a significantly lower risk of cardiovascular disease than patients who continued to smoke (HR 0.83, 95% CI 0.70 to 0.99) as well as recent quitters with a coinciding weight gain of 0.1 kg to 5 kg (HR 0.89, 95% CI 0.65 to 1.23), or more than 5 kg (HR 0.72, 95% CI 0.61 to 0.84). The findings of this study therefore reemphasize the importance of smoking cessation in reducing the risk of developing cardiovascular disease, morbidity and mortality. However, the importance of body weight management following cessation must also be communicated to patients, as associated weight gain can attenuate the positive effects of smoking cessation.

Click to read the study in Lancet Diabetes and Endocrinology

Image: PD

RELATED REPORTS

Sleeve gastrectomy may produce greater and more durable weight loss than semaglutide in patients with obesity

Oral semaglutide reshapes everyday obesity visits

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obesitysmokingsmoking cessationweight control
Previous Post

Law enforcement and health care officials should partner to prevent gun violence

Next Post

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes 

RelatedReports

Many new pediatric asthma cases attributable to obesity
Chronic Disease

Sleeve gastrectomy may produce greater and more durable weight loss than semaglutide in patients with obesity

January 30, 2026
Tramadol use linked with increased risk of hypoglycemia hospitalizations
Cardiology

Oral semaglutide reshapes everyday obesity visits

February 3, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

January 26, 2026
Fatty liver disease may independently predict high-risk coronary disease
Chronic Disease

Berberine is safe and effective in lowering lipoprotein cholesterol levels in metabolic dysfunction-associated steatotic liver disease

January 19, 2026
Next Post
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes 

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes 

Rivaroxaban after TAVR linked with increased risk of adverse events compared to antiplatelet therapy

Rivaroxaban after TAVR linked with increased risk of adverse events compared to antiplatelet therapy

Depression linked with diagnosis of dementia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early menarche and later menopause are associated with increased ovarian cancer risk
  • A telephone-based intervention reduced loneliness and improved well-being among older adults
  • Propofol is associated with lower mortality in sepsis-associated encephalopathy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.